CBE ID
3755e
Endorsed
Endorsement Status
1.1 New or Maintenance
Is Under Review
No
Next Planned Maintenance Review
Spring 2028
1.3 Measure Description
Percentage of patients 13 years of age and older with a diagnosis of HIV who had tests for syphilis, gonorrhea, and chlamydia performed within the measurement period.
-
-
1.5 Measure Type1.8 Level Of Analysis1.20 Testing Data Sources
-
1.14 Numerator
Patients who had a test for syphilis, a test for gonorrhea, and a test for chlamydia performed at least once during the measurement period.
-
1.15 Denominator
All patients 13 years of age and older with a diagnosis of HIV before the end of the measurement period seen for an eligible encounter during the measurement period.
-
Exclusions
Not applicable.
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityPrimary Care and Chronic Illness Spring 2023Initial Endorsement
-
Steward Organization Email
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Spring 2023 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Spring 2023 “Intent to Submit.” Battelle took over the E&M work for the Spring 2023 cycle when developers and/or stewards submitted their full measure information, which for CBE #3755e, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2023-06/3755e_-_sti_testing.zip
To close out this E&M cycle, Battelle published the Spring 2023 measures for pre-evaluation public commenting, convened the E&M standing committees for their measure evaluation meetings, launched the Spring 2023 post-comment period, convened the E&M committees for the post-comment meeting, convened the CSAC to render a final endorsement decision, and executed the appeals period.